VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 175 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $213,000 | -4.1% | 5,092 | 0.0% | 0.06% | -14.5% |
Q3 2021 | $222,000 | -4.3% | 5,092 | 0.0% | 0.08% | -10.6% |
Q1 2021 | $232,000 | -54.6% | 5,092 | -73.3% | 0.08% | -58.7% |
Q4 2020 | $511,000 | -38.1% | 19,092 | -9.5% | 0.21% | -44.2% |
Q3 2020 | $825,000 | – | 21,092 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |